disciplines will be developed for all direct to store purchases made by retailers following successful trials on chilled pastry and cakes categories
Received FDA orphan drug designation for BLU-554 for HCC: In September, Blueprint
Medicines announced that the FDA granted orphan drug designation to BLU-554 for the treatment of HCC.
NFF President Duncan Fraser said he is looking forward to turning the key strategies outlined in the Blueprint
In addition, utilizing its proprietary platform, Blueprint
Medicines has predicted resistance mutations in the neurotrophic tyrosine receptor kinase (NTRK).
1] For every million websites end users of BluePrint
Data's customers visit over 99.
Data is very excited about this challenge,” said Bob Dahlstrom BluePrint
transforms the business-IT relationship into a visual and engaging collaboration, enabling a unified approach that results in on-time, and on-budget applications.
Led by a team of industry innovators, Blueprint
Medicines integrates a novel target discovery engine and a proprietary compound library to understand the blueprint
of cancer and craft highly selective therapies.
Data is happy to extend our Zero False Positive Internet Filtering promotion until the end of September 2012 to continue proving our value to potential customers,” said Bob Dahlstrom BluePrint
dramatically improves the software development lifecycle, accelerating delivery times and reducing costs for hundreds of major corporations.
3, 2015 /PRNewswire/ -- Blueprint
Medicines (NASDAQ: BPMC), a leader in discovering and developing highly selective kinase drugs for genomically defined diseases, today announced that Jeffrey Albers, chief executive officer, will present a company overview at BioCentury's 22nd Annual NewsMakers in the Biotech Industry Conference on Thursday, September 10, 2015 at 3:00 p.
Data today announced the beta release of its private label brandable cloud based DNS Internet Filtering Services.